Literature DB >> 14500639

IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.

Salim Dhanji1, Hung-Sia Teh.   

Abstract

CD8(+) T cells depend on the alphabeta TCR for Ag recognition and function. However, Ag-activated CD8(+) T cells can also express receptors of the innate immune system. In this study, we examined the expression of NK receptors on a population of CD8(+) T cells expressing high levels of CD44 (CD8(+)CD44(high) cells) from normal mice. These cells are distinct from conventional memory CD8(+) T cells and they proliferate and become activated in response to IL 2 via a CD48/CD2-dependent mechanism. Before activation, they express low or undetectable levels of NK receptors but upon activation with IL-2 they expressed significant levels of activating NK receptors including 2B4 and NKG2D. Interestingly, the IL-2-activated cells demonstrate a preference in the killing of syngeneic tumor cells. This killing of syngeneic tumor cells was greatly enhanced by the expression of the NKG2D ligand Rae-1 on the target cell. In contrast to conventional CD8(+) T cells, IL-2-activated CD8(+)CD44(high) cells express DAP12, an adaptor molecule that is normally expressed in activated NK cells. These observations indicate that activated CD8(+)CD44(high) cells express receptors of both the adaptive and innate immune system and may play a unique role in the surveillance of host cells that have been altered by infection or transformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500639     DOI: 10.4049/jimmunol.171.7.3442

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  ITK and IL-15 support two distinct subsets of CD8+ T cells.

Authors:  Sigrid Dubois; Thomas A Waldmann; Jürgen R Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

Review 2.  Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia.

Authors:  Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

3.  The ThPOK transcription factor differentially affects the development and function of self-specific CD8(+) T cells and regulatory CD4(+) T cells.

Authors:  Yuh-Ching Twu; Hung-Sia Teh
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 4.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

5.  Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells.

Authors:  Dmitry Isakov; Amiran Dzutsev; Jay A Berzofsky; Igor M Belyakov
Journal:  Eur J Immunol       Date:  2011-12       Impact factor: 5.532

Review 6.  NKG2D ligands as therapeutic targets.

Authors:  Paul Spear; Ming-Ru Wu; Marie-Louise Sentman; Charles L Sentman
Journal:  Cancer Immun       Date:  2013-05-01

7.  Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.

Authors:  Kyung-Mi Lee; John P Forman; Megan E McNerney; Susan Stepp; Sumalatha Kuppireddi; Dustin Guzior; Yvette E Latchman; Mohamed H Sayegh; Hideo Yagita; Chul-Kyu Park; Seog Bae Oh; Christoph Wülfing; John Schatzle; Porunelloor A Mathew; Arlene H Sharpe; Vinay Kumar
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

Review 8.  Melanoma, Darwinian medicine and the inner world.

Authors:  B Krone; J M Grange
Journal:  J Cancer Res Clin Oncol       Date:  2010-09-18       Impact factor: 4.553

9.  NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.

Authors:  Kevin B Walsh; Lewis L Lanier; Thomas E Lane
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse.

Authors:  Steve Oghumu; Ran Dong; Sanjay Varikuti; Todd Shawler; Thomas Kampfrath; Cesar A Terrazas; Claudio Lezama-Davila; Brian M M Ahmer; Caroline C Whitacre; Sanjay Rajagopalan; Richard Locksley; Arlene H Sharpe; Abhay R Satoskar
Journal:  J Immunol       Date:  2013-01-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.